Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1990 | 1 |
2009 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry).
BMJ Open Diabetes Res Care. 2021 Jan;9(1):e001787. doi: 10.1136/bmjdrc-2020-001787.
BMJ Open Diabetes Res Care. 2021.
PMID: 33441417
Free PMC article.
Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
Gottschall PE, Tatsuno I, Miyata A, Arimura A.
Gottschall PE, et al. Among authors: tatsuno i.
Endocrinology. 1990 Jul;127(1):272-7. doi: 10.1210/endo-127-1-272.
Endocrinology. 1990.
PMID: 2361473
Item in Clipboard
cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
Nagata A, Tanaka T, Minezawa A, Poyurovsky M, Mayama T, Suzuki S, Hashimoto N, Yoshida T, Suyama K, Miyata A, Hosokawa H, Nakayama T, Tatsuno I.
Nagata A, et al. Among authors: tatsuno i.
J Cell Physiol. 2009 Oct;221(1):75-83. doi: 10.1002/jcp.21831.
J Cell Physiol. 2009.
PMID: 19496170
Item in Clipboard
Cite
Cite